SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001326389-24-000119
Filing Date
2024-02-14
Accepted
2024-02-14 13:46:36
Documents
1
Group Members
CDL@POLARAMP.COM

Document Format Files

Seq Description Document Type Size
1 AEON Aeon.txt SC 13G 5233
  Complete submission text file 0001326389-24-000119.txt   7027
Mailing Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6
Business Address 16 YORK STREET SUITE 2900 TORONTO A6 M5J 0E6 416-367-4364
Polar Asset Management Partners Inc. (Filed by) CIK: 0001326389 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: SC 13G

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Subject) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92271 | Film No.: 24635685
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)